Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals

NCT01862029 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Obesity

Interventions

DRUG: Roflumilast

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)